Under the requirement, providers will be reimbursed at least $90 for giving two doses of the Moderna or Pfizer-BioNTech vaccine to members of MassHealth — the name of the state’s Medicaid program — or private health plans. The rate for Johnson & Johnson’s vaccine hasn’t been set yet.
The increase is intended to encourage quick vaccination of the state’s residents, administration officials told the Globe. It’s not a common step other states have taken. Most state Medicaid programs are paying the $45 Medicare rate for the vaccine, Matt Salo, executive director of the National Association of Medicaid Directors, told the newspaper.
While hospitals welcomed the increased reimbursement, Massachusetts insurers expect to spend roughly $400 million on COVID-19 vaccine reimbursement this year, according to the Globe. Those costs will likely be built into insurance premiums.
Read the full report here.
More articles on healthcare finance:
Tennessee hospital abruptly closes
Tennessee hospital loses staff, hasn’t admitted patients since November
15 health systems with strong finances
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
